文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

功能磁共振成像在宫颈癌近距离放疗后PET/CT不完全缓解患者中的应用

Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-02-06

该回顾性研究纳入244例接受同步放化疗及影像引导高剂量率近距离放疗的宫颈癌患者,探讨PET/CT缓解与预后的关系,并评估弥散加权MRI(DW-MRI)对PET/CT不完全缓解(PET-IR)患者的补充价值。结果显示PET完全缓解(PET-CR)者2年总生存率显著优于PET-IR者,DW-MRI阳性与局部复发及更差生存相关。

要点

  • PET/CT完全缓解者2年总生存率94%,不完全缓解者62.4%,差异显著。
  • PET-IR患者中32%出现局部复发,DW-MRI阳性者81.8%确认局部复发。
  • DW-MRI阴性者2年总生存率83%,阳性者36%,差异有统计学意义。

核心结论

  • 影像引导近距离放疗后约20%宫颈癌患者PET/CT显示不完全缓解。
  • 整合DW-MRI有助于准确识别持续病灶风险及长期预后较差的患者。
  • DW-MRI的价值需在大样本前瞻性数据集中进一步验证。

研究设计与样本

  • 回顾性图表审查,纳入2007至2016年间244例FIGO IB1-IVA期宫颈癌患者。
  • 患者均接受同步放化疗及影像引导高剂量率近距离放疗,分5次宫腔内/组织间插植,每次5-6 Gy。

主要发现

  • 治疗后中位3.3个月(范围2.1-7.7个月)PET/CT完全缓解者50/244例(20%)。
  • 中位随访27个月,全组2年总生存率83%。
  • PET-IR患者中16/50例(32%)出现局部复发。
  • 27例PET-IR患者行DW-MRI,中心判读11/27例(40%)阳性,中位ADC值0.973×10⁻³ mm²/s。
  • DW-MRI阳性者9/11例(81.8%)组织学证实局部复发,阴性者2/16例(12.5%)局部复发。

关键数值与推荐

  • PET-CR者2年总生存率94%,PET-IR者62.4%,P < .001。
  • DW-MRI阴性者2年总生存率83%,阳性者36%,P = .049。

临床怎么用

  • 对影像引导近距离放疗后PET/CT不完全缓解的宫颈癌患者,可考虑补充DW-MRI以评估持续病灶风险。
  • DW-MRI阳性提示局部复发风险高及长期生存较差,可能有助于早期评估和挽救治疗决策。

局限性

  • 回顾性研究设计,DW-MRI仅在部分PET-IR患者中实施(27/50例)。
  • DW-MRI的价值尚需大样本前瞻性数据集验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the correlation between positron emission tomography/computed tomography (PET/CT) response and outcome in the era of magnetic resonance imaging (MRI)-based planning and to assess whether the addition of diffusion-weighted MRI (DW-MRI) could more accurately classify treatment response and prognosis. METHODS AND MATERIALS: A retrospective chart review identified 244 consecutive patients with International Federation of Gynecology and Obstetrics stage IB1-IVA cervical cancer treated with concurrent chemoradiation, including high-dose-rate image-based brachytherapy, between 2007 and 2016. Image-based brachytherapy was delivered with 5 intracavitary/interstitial fractions, each 5 to 6 Gy per fraction. RESULTS: An complete response on posttreatment PET/CT (PET-CR) was discovered in 50 of 244 patients (20%) at a median interval of 3.3 months (range, 2.1-7.7 months) after treatment. After a median follow-up of 27 months, 2-year overall survival was 83% in all patients. Metabolic response significantly impacted 2-year overall survival (94% complete response on posttreatment PET/ CT vs 62.4% PET-IR, P < .001). Of those with a PET-IR, 16 of 50 patients (32%) suffered a local recurrence. A total of 27 of 50 patients with a PET-IR underwent DW-MRI; 11 of 27 posttreatment DW-MRI scans (40%) were interpreted as positive by central review (median apparent diffusion coefficient of 0.973 × 10-3 mm2/s). Of the DW-MRI-positive patients, 9 of 11 (81.8%) suffered a histologically confirmed local recurrence, and 2 of 11 patients are without evidence of disease. Additionally, 16 of 27 DW-MRI studies were interpreted as negative, and 2 of 16 (12.5%) of these patients suffered a local recurrence. Diffusion-weighted MRI findings significantly impacted 2-year overall survival (83% negative DW-MRI vs 36% positive DW-MRI, P = .049). CONCLUSION: Incomplete PET/CT response was documented in 20% of patients after image-based brachytherapy for locally advanced cervical cancer. Integration of DW-MRI helped accurately identify patients at risk for persistent disease and worse long-term outcome. The value of DW-MRI requires further validation in a large prospective dataset as this modality may allow earlier evaluation and salvage treatment in those with PET-IR.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Kalash R, Glaser SM, Rangaswamy B, et al. Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 29559287. doi:10.1016/j.ijrobp.2018.01.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。